Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587678 · ClinicalTrials.gov registry record · NA
Comprehensive Magnetic Resonance of Peripheral Arterial Disease
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT00587678 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 85 participants.
The verdict
NCT00587678, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to develop new ways of imaging fatty blockages in the leg arteries to improve upon techniques used now and to develop new ways of understanding how new treatments may affect the disease.
Interventions
- DRUG Simvastatin
- DRUG Ezetimibe
- DRUG Simvastatin/Ezetimibe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587678
The ClinicalTrials.gov registry entry for NCT00587678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Simvastatin is the first listed.
NCT00587678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587678 about?
NCT00587678 is a clinical study titled "Comprehensive Magnetic Resonance of Peripheral Arterial Disease". The purpose of this study is to develop new ways of imaging fatty blockages in the leg arteries to improve upon techniques used now and to develop new ways of understanding how new treatments may affect the disease.
What is the current status of trial NCT00587678?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2006-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00587678?
The interventions under investigation include: Simvastatin (DRUG), Ezetimibe (DRUG), Simvastatin/Ezetimibe (DRUG).
Who is sponsoring clinical trial NCT00587678?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.